Study of the Effects of Artificial Tears on the Response to the Latanoprost Punctal Plug Delivery System in Subjects With Ocular Hypertension or Open-Angle Glaucoma

Completed · Phase 2

Conditions studied: Glaucoma, Ocular Hypertension

In brief

The purpose of this study is to determine the effect of artificial tears preserved with Benzalkonium Chloride (AT-BAK) on the IOP response to the L-PPDS and to evaluate the safety of the L-PPDS in subjects with OH or OAG following treatment.

Key facts

Study ID

NCT00845299

Run by

Mati Therapeutics Inc.

People needed

40

Starts

2009-01-01

Expected to finish

2009-12-01

Last updated by the study team

2013-09-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 years with ocular hypertension or open-angle glaucoma
• Subjects who have a best-corrected visual acuity of 20/100 or better

You may not qualify if…

• Subjects who wear contact lenses
• Uncontrolled medical conditions
• Subjects with a known sensitivity to latanoprost, BAK, or any other products required for the study
• Subjects requiring chronic topical artificial tears, lubricants, and/or requiring any other chronic topical medications.

Where it is running

• Study site — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.